Standex International (SXI) Financials

$145.88 -1.43 (-0.97%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$145.74 -0.14 (-0.10%)

As of 05/23/2025 04:04 PM Eastern

Annual Income Statements for Standex International

This table shows Standex International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015	6/30/2014
Net Income / (Loss) Attributable to Common Shareholders	73	139	61	36	20	68	37	47	52	55	43
Consolidated Net Income / (Loss)	73	139	61	36	20	68	37	47	52	55	43
Net Income / (Loss) Continuing Operations	74	139	61	39	41	48	30	39	52	55	50
Total Pre-Tax Income	95	164	81	53	54	67	68	51	69	76	68
Total Operating Income	102	171	88	59	61	79	78	57	70	79	66
Total Gross Profit	282	285	270	241	215	235	226	216	252	247	238
Total Revenue	721	741	735	656	605	640	596	648	752	772	716
Operating Revenue	721	741	735	656	605	640	596	648	752	772	716
Total Cost of Revenue	439	456	465	415	389	405	370	432	499	525	478
Operating Cost of Revenue	439	456	465	415	389	405	370	432	499	525	478
Total Operating Expenses	180	114	182	182	155	155	148	159	182	169	172
Selling, General & Admin Expense	170	172	170	163	148	150	141	145	170	166	166
Other Operating Expenses / (Income)	0.11	-0.61	5.75	0.00	0.00	0.50	0.00	0.00	7.46	-0.44	-3.46
Restructuring Charge	11	4.39	6.02	4.41	6.43	4.36	7.18	14	4.23	3.44	10
Other Special Charges / (Income)	-0.27	-62	0.00	15	-	-	-	-	-	-	-
Total Other Income / (Expense), net	-6.62	-7.14	-7.01	-6.47	-6.45	-13	-9.75	-5.96	-1.82	-2.53	1.94
Interest Expense	4.54	5.41	5.87	5.99	7.48	11	8.03	4.04	2.87	3.16	2.25
Other Income / (Expense), net	-2.07	-1.74	-1.13	-0.47	1.02	-1.74	-1.72	-1.92	1.05	0.63	4.18
Income Tax Expense	22	25	20	14	13	19	38	12	16	21	18
Net Income / (Loss) Discontinued Operations	-0.52	-0.16	-0.09	-2.07	-21	20	6.24	7.41	-0.17	-0.50	-6.88
Basic Earnings per Share	$6.22	$11.77	$5.13	$3.00	$1.64	$5.40	$2.88	$3.68	$4.11	$4.33	$3.39
Weighted Average Basic Shares Outstanding	11.85M	11.85M	11.97M	12.21M	12.38M	12.45M	12.70M	12.67M	12.68M	12.66M	12.61M
Diluted Earnings per Share	$6.14	$11.58	$5.06	$2.97	$1.63	$5.38	$2.86	$3.65	$4.08	$4.27	$3.35
Weighted Average Diluted Shares Outstanding	11.85M	11.85M	11.97M	12.21M	12.38M	12.45M	12.70M	12.67M	12.68M	12.66M	12.61M
Weighted Average Basic & Diluted Shares Outstanding	11.85M	11.85M	11.97M	12.21M	12.38M	12.45M	12.70M	12.67M	12.68M	12.66M	12.61M
Cash Dividends to Common per Share	$1.18	$1.10	$1.02	$0.94	$0.86	$0.78	$0.70	-	-	$0.46	$0.38

This table shows Standex International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	22	0.86	18	20	16	19	19	20	81	20	18
Consolidated Net Income / (Loss)	23	1.28	18	20	16	19	19	20	81	20	18
Net Income / (Loss) Continuing Operations	23	1.29	18	20	16	19	19	20	81	20	18
Total Pre-Tax Income	18	2.00	23	26	20	24	25	27	86	26	24
Total Operating Income	26	8.46	24	27	22	26	27	28	89	28	26
Total Gross Profit	82	71	70	69	68	72	73	74	71	72	68
Total Revenue	208	190	170	180	177	178	185	188	184	188	181
Operating Revenue	208	190	170	180	177	178	185	188	184	188	181
Total Cost of Revenue	125	118	100	111	109	107	112	115	113	115	112
Operating Cost of Revenue	125	118	100	111	109	107	112	115	113	115	112
Total Operating Expenses	56	63	46	42	46	46	46	45	-18	45	42
Selling, General & Admin Expense	52	46	43	41	42	43	44	45	43	44	41
Other Operating Expenses / (Income)	0.00	-	0.00	0.27	0.11	0.00	-0.27	-	-0.73	0.12	0.00
Restructuring Charge	4.13	17	2.93	1.29	4.57	2.56	2.41	0.57	2.26	0.69	0.87
Other Special Charges / (Income)	0.00	0.00	-	-	0.00	-	-	-	-62	0.00	-
Total Other Income / (Expense), net	-8.67	-6.47	-0.95	-1.57	-1.58	-1.35	-2.12	-1.28	-2.16	-1.50	-2.21
Interest Expense	8.36	5.58	0.98	1.30	0.95	1.02	1.28	1.24	1.42	1.57	1.19
Other Income / (Expense), net	-0.31	-0.89	0.03	-0.27	-0.63	-0.33	-0.85	-0.04	-0.75	0.07	-1.02
Income Tax Expense	-5.20	0.71	4.96	5.89	4.33	5.41	5.90	7.01	5.79	6.23	5.77
Net Income / (Loss) Discontinued Operations	-0.05	-0.01	0.01	-0.10	-0.14	-0.20	-0.08	-0.02	-0.06	-0.04	-0.05
Net Income / (Loss) Attributable to Noncontrolling Interest	0.85	0.42	-	-	-	0.00	-	-	-	-	-
Basic Earnings per Share	$1.83	$0.07	$1.54	$1.68	$1.34	$1.60	$1.60	$1.71	$6.82	$1.69	$1.55
Weighted Average Basic Shares Outstanding	11.99M	11.94M	11.79M	11.85M	11.77M	11.79M	11.74M	11.85M	11.81M	11.85M	11.82M
Diluted Earnings per Share	$1.81	$0.07	$1.53	$1.64	$1.33	$1.59	$1.58	$1.59	$6.77	$1.69	$1.53
Weighted Average Diluted Shares Outstanding	12.06M	12.03M	11.90M	11.85M	11.85M	11.86M	11.93M	11.85M	11.90M	11.92M	11.95M
Weighted Average Basic & Diluted Shares Outstanding	12.07M	11.90M	12.08M	11.85M	11.85M	11.87M	11.90M	11.85M	11.90M	11.94M	11.99M
Cash Dividends to Common per Share	$0.32	$0.32	$0.30	$0.30	$0.30	$0.30	$0.28	$0.28	$0.28	$0.28	$0.26

This table details how cash moves in and out of Standex International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015	6/30/2014
Net Change in Cash & Equivalents	-42	91	-32	18	26	-16	21	-33	26	22	23
Net Cash From Operating Activities	93	91	78	84	47	73	65	63	80	64	70
Net Cash From Continuing Operating Activities	93	91	78	82	55	73	52	51	81	66	72
Net Income / (Loss) Continuing Operations	74	139	61	39	41	48	30	39	52	55	50
Consolidated Net Income / (Loss)	73	139	61	36	20	68	37	47	52	55	43
Net Income / (Loss) Discontinued Operations	-0.52	-0.16	-0.09	-2.07	-21	20	6.24	7.41	-0.17	-0.50	-6.88
Depreciation Expense	28	28	30	33	32	29	25	18	18	17	15
Non-Cash Adjustments To Reconcile Net Income	9.69	-51	12	22	6.11	4.02	3.04	6.44	14	1.51	12
Changes in Operating Assets and Liabilities, net	-18	-26	-25	-12	-25	-8.89	-6.46	-13	-3.04	-7.27	-4.24
Net Cash From Discontinued Operating Activities	-0.69	0.03	-0.42	1.72	-7.44	0.42	13	13	-0.90	-2.13	-1.69
Net Cash From Investing Activities	-62	42	-31	-39	-0.62	-50	-32	-179	-29	-79	-33
Net Cash From Continuing Investing Activities	-62	42	-31	-39	-21	-158	-29	-178	-32	-79	-36
Purchase of Property, Plant & Equipment	-20	-24	-24	-22	-22	-33	-24	-25	-18	-23	-19
Acquisitions	-49	0.00	-13	-27	-0.62	-128	-10	-154	-14	-57	-23
Sale of Property, Plant & Equipment	0.00	1.74	1.82	0.12	0.18	3.16	2.85	1.11	0.38	0.07	0.12
Divestitures	7.77	67	0.00	12	0.00	0.00	-	-	-	-	-
Other Investing Activities, net	-0.27	-2.93	4.01	-1.73	1.34	-0.38	1.82	0.11	-0.42	1.13	6.17
Net Cash From Discontinued Investing Activities	0.00	0.00	0.00	0.00	20	108	-2.97	-0.99	2.80	0.00	2.45
Net Cash From Financing Activities	-69	-40	-69	-32	-19	-38	-12	85	-21	45	-15
Net Cash From Continuing Financing Activities	-69	-40	-69	-32	-19	-38	-12	85	-21	45	-15
Repayment of Debt	-25	-226	-25	-17	-105	-237	-165	-164	-75	-217	-76
Repurchase of Common Equity	-32	-26	-31	-21	-10	-33	-2.65	-7.81	-5.64	-10	-7.79
Payment of Dividends	-14	-13	-12	-11	-11	-9.83	-8.89	-7.85	-6.85	-5.82	-4.79
Issuance of Debt	0.00	225	0.00	17	107	242	164	264	65	275	71
Issuance of Common Equity	1.53	1.34	1.42	1.27	1.74	1.13	0.92	0.85	0.94	0.70	1.10
Other Financing Activities, net	0.00	-1.17	-2.17	-0.36	-0.87	-0.91	0.00	0.00	0.80	2.09	1.65
Other Net Changes in Cash	-3.33	-1.46	-	4.80	-1.98	-	0.29	-	-	-	-
Cash Interest Paid	4.09	4.23	4.75	4.90	6.32	9.47	6.18	3.26	2.35	2.55	1.83
Cash Income Taxes Paid	28	26	18	17	19	24	22	20	25	13	14

This table details how cash moves in and out of Standex International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-11	-43	10	15	-3.63	16	-69	20	62	10	-1.42
Net Cash From Operating Activities	9.54	9.06	18	29	24	24	16	40	23	30	-2.70
Net Cash From Continuing Operating Activities	9.55	9.12	18	29	24	24	16	40	23	30	-2.71
Net Income / (Loss) Continuing Operations	23	1.29	18	20	16	19	19	20	81	20	18
Consolidated Net Income / (Loss)	23	1.28	18	20	16	19	19	20	81	20	18
Net Income / (Loss) Discontinued Operations	-0.05	-0.01	0.01	-0.10	-0.14	-0.20	-0.08	-0.02	-0.06	-0.04	-0.05
Depreciation Expense	9.74	8.51	7.06	6.99	7.18	6.89	7.08	7.20	7.31	6.96	7.01
Non-Cash Adjustments To Reconcile Net Income	-22	0.71	-4.32	0.54	4.25	-13	2.32	39	-65	-27	1.50
Changes in Operating Assets and Liabilities, net	-1.39	-1.39	-3.38	1.51	-2.92	10	-12	-26	-0.05	29	-30
Net Cash From Discontinued Operating Activities	-0.01	-0.06	0.03	-0.19	-0.08	-0.20	-0.23	0.07	0.01	-0.05	0.00
Net Cash From Investing Activities	-64	-423	-6.31	-7.67	-16	-4.25	-33	-7.49	60	-5.71	-5.22
Net Cash From Continuing Investing Activities	-64	-423	-6.31	-7.67	-16	-4.25	-33	-7.49	60	-5.71	-5.22
Purchase of Property, Plant & Equipment	-6.07	-6.97	-6.73	-6.53	-5.18	-4.25	-4.34	-7.62	-5.62	-5.76	-5.27
Acquisitions	-58	-420	0.00	-1.14	-18	-	-29	-	-	-	0.00
Other Investing Activities, net	-0.10	3.49	0.41	-	-0.27	-	0.00	-1.61	-1.42	0.06	0.04
Net Cash From Financing Activities	41	376	-6.27	-3.37	-8.53	-7.62	-50	-10	-22	-20	12
Net Cash From Continuing Financing Activities	41	376	-6.27	-3.37	-8.53	-7.62	-50	-10	-22	-20	12
Repayment of Debt	-23	-339	0.00	-	-	-	-25	-	-210	-16	0.00
Payment of Dividends	-3.84	-3.83	-3.53	-3.53	-3.54	-3.55	-3.29	-3.29	-3.30	-3.33	-3.07
Issuance of Debt	68	-	-	-	-	-	-	-	196	4.50	24
Issuance of Common Equity	0.23	0.16	1.64	0.20	0.14	0.42	0.77	0.17	0.18	0.16	0.84
Other Net Changes in Cash	1.64	-5.70	5.40	-	-	-	-	-2.51	0.92	-	-
Cash Interest Paid	9.68	2.66	0.90	1.01	0.86	0.94	1.28	1.05	0.96	1.13	1.10
Cash Income Taxes Paid	11	0.77	5.48	8.23	5.73	8.89	5.12	4.13	9.24	3.40	9.42

This table presents Standex International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015	6/30/2014
Total Assets	1,005	1,025	934	962	931	922	917	868	690	659	578
Total Current Assets	430	483	379	374	332	334	384	361	356	335	300
Cash & Equivalents	154	196	105	136	119	93	110	89	122	96	74
Accounts Receivable	121	123	117	110	98	103	120	127	104	110	108
Inventories, net	87	99	105	92	85	76	104	119	105	108	97
Prepaid Expenses	22	34	45	24	19	22	10	8.40	4.78	7.07	7.03
Other Current Assets	45	31	-	-	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	135	131	129	133	133	134	137	133	107	109	97
Total Noncurrent Assets	440	411	427	454	466	454	396	374	228	215	182
Goodwill	281	265	268	278	271	274	212	243	157	155	126
Intangible Assets	79	76	86	99	106	119	85	103	40	38	31
Noncurrent Deferred & Refundable Income Taxes	17	15	8.19	9.57	17	14	7.45	1.14	11	0.92	0.88
Other Noncurrent Operating Assets	63	56	65	68	71	25	30	27	19	21	23
Total Liabilities & Shareholders' Equity	1,005	1,025	934	962	931	922	917	868	690	659	578
Total Liabilities	384	417	435	456	469	458	466	459	320	310	237
Total Current Liabilities	128	141	151	144	123	142	161	160	134	139	141
Accounts Payable	63	69	75	75	55	54	79	96	77	81	85
Accrued Expenses	57	62	68	62	60	50	58	59	51	48	51
Current Deferred & Payable Income Tax Liabilities	7.50	10	8.48	7.24	7.43	5.74	6.05	4.78	4.70	10	4.93
Total Noncurrent Liabilities	256	277	284	312	346	316	305	299	186	172	96
Long-Term Debt	149	173	175	199	199	198	194	192	92	102	45
Other Noncurrent Operating Liabilities	107	103	109	113	147	0.00	26	11	10	9.16	8.54
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.00	-	-	-	-	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	622	607	499	506	462	464	451	409	370	349	341
Total Preferred & Common Equity	622	607	499	506	462	464	451	409	370	349	341
Total Common Equity	622	607	499	506	462	464	451	409	370	349	341
Common Stock	148	143	133	123	115	107	103	99	94	89	85
Retained Earnings	1,086	1,027	901	852	828	818	761	717	678	633	584
Treasury Stock	-430	-404	-382	-353	-333	-324	-292	-291	-284	-281	-273
Accumulated Other Comprehensive Income / (Loss)	-183	-158	-153	-116	-148	-137	-122	-116	-118	-93	-56

This table presents Standex International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	3/31/2024	12/31/2023	9/30/2023	3/31/2023	12/31/2022	9/30/2022	3/31/2022
Total Assets	1,555	1,483	1,038	994	1,005	981	1,015	957	921	974
Total Current Assets	487	465	447	419	436	420	461	401	385	411
Cash & Equivalents	110	121	165	139	142	127	175	113	103	134
Accounts Receivable	170	153	119	121	126	127	121	120	114	115
Inventories, net	120	104	90	95	99	98	105	106	110	104
Prepaid Expenses	29	31	24	62	66	67	57	49	51	42
Other Current Assets	58	56	50	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	147	138	138	135	133	129	131	130	125	128
Total Noncurrent Assets	921	880	452	439	436	432	424	426	412	435
Goodwill	611	587	292	282	280	275	269	270	261	275
Intangible Assets	227	208	79	82	83	84	80	82	82	92
Noncurrent Deferred & Refundable Income Taxes	17	22	19	15	14	14	9.21	7.40	6.46	5.37
Other Noncurrent Operating Assets	67	64	62	60	59	59	65	63	62	63
Total Liabilities & Shareholders' Equity	1,555	1,483	1,038	994	1,005	981	1,015	957	921	974
Total Liabilities	840	800	380	375	384	387	410	427	430	446
Total Current Liabilities	143	138	126	122	131	132	131	132	124	142
Accounts Payable	76	73	67	58	64	62	68	66	66	75
Accrued Expenses	59	60	53	55	56	60	56	53	53	57
Current Deferred & Payable Income Tax Liabilities	7.17	5.18	6.61	8.45	11	9.90	7.37	9.78	4.71	9.28
Total Noncurrent Liabilities	697	662	254	252	254	255	279	295	305	304
Long-Term Debt	579	534	149	149	149	149	173	188	199	200
Other Noncurrent Operating Liabilities	118	128	105	103	105	107	106	107	106	104
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	28	27	-	-	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	687	656	658	619	621	595	606	529	492	528
Total Preferred & Common Equity	687	656	658	619	621	595	606	529	492	528
Total Common Equity	687	656	658	619	621	595	606	529	492	528
Common Stock	177	174	150	147	143	141	139	135	133	130
Retained Earnings	1,116	1,098	1,101	1,070	1,058	1,043	1,010	933	917	891
Treasury Stock	-428	-428	-432	-430	-425	-421	-397	-392	-387	-372
Accumulated Other Comprehensive Income / (Loss)	-178	-188	-161	-168	-156	-168	-147	-147	-171	-122

This table displays calculated financial ratios and metrics derived from Standex International's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015	6/30/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.75%	0.78%	12.05%	8.55%	-5.53%	7.46%	-8.08%	-13.80%	-2.66%	7.81%	6.35%
EBITDA Growth	-35.39%	69.29%	27.11%	-2.04%	-12.31%	5.49%	39.34%	-18.51%	-6.89%	13.37%	9.92%
EBIT Growth	-41.15%	94.30%	48.51%	-4.64%	-20.82%	1.72%	38.94%	-22.96%	-9.94%	13.17%	13.41%
NOPAT Growth	-45.80%	117.45%	54.33%	-5.75%	-19.88%	65.15%	-20.63%	-18.47%	-6.06%	18.10%	5.10%
Net Income Growth	-47.43%	126.40%	68.32%	80.67%	-70.27%	85.54%	-21.36%	-10.59%	-4.91%	27.71%	-4.42%
EPS Growth	-46.98%	128.85%	70.37%	82.21%	-69.70%	88.11%	-21.64%	-10.54%	-4.45%	27.46%	-4.56%
Operating Cash Flow Growth	2.04%	16.84%	-7.02%	76.92%	-35.59%	12.97%	2.34%	-21.02%	25.43%	-8.90%	16.81%
Free Cash Flow Firm Growth	-63.11%	93.07%	401.11%	-72.78%	254.90%	-134.13%	171.97%	-288.31%	375.99%	-19.48%	484.73%
Invested Capital Growth	5.30%	2.78%	-0.04%	5.54%	-0.59%	19.61%	-11.37%	50.94%	-4.22%	13.70%	10.83%
Revenue Q/Q Growth	-1.12%	0.49%	1.14%	5.99%	-18.74%	64.22%	-12.00%	-11.48%	-0.79%	0.32%	6.22%
EBITDA Q/Q Growth	-1.36%	5.10%	-4.45%	15.34%	-8.56%	-3.00%	11.96%	-7.15%	-8.73%	5.38%	3.86%
EBIT Q/Q Growth	-1.54%	6.07%	-4.73%	25.22%	-12.86%	-6.71%	14.07%	-8.27%	-11.30%	5.84%	4.78%
NOPAT Q/Q Growth	-0.29%	4.60%	-1.84%	26.08%	-14.11%	5.94%	7.37%	-4.64%	-8.01%	5.37%	4.28%
Net Income Q/Q Growth	-0.78%	5.22%	-1.10%	49.74%	-34.34%	-0.33%	-4.01%	4.38%	-7.45%	13.08%	-5.40%
EPS Q/Q Growth	0.82%	3.67%	0.00%	0.00%	-34.27%	0.19%	-4.03%	4.29%	-7.27%	13.26%	-5.63%
Operating Cash Flow Q/Q Growth	-11.41%	13.81%	-3.18%	14.69%	-35.90%	18.72%	6.19%	-2.09%	-10.08%	10.98%	-9.41%
Free Cash Flow Firm Q/Q Growth	-10.95%	0.52%	70.49%	-48.27%	-27.96%	-183.69%	1,457.27%	-36.08%	-9.21%	167.49%	-83.41%
Invested Capital Q/Q Growth	-2.03%	-3.05%	-4.07%	0.85%	-2.99%	-4.93%	-18.20%	-0.69%	-9.52%	-9.68%	-1.62%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	39.13%	38.47%	36.71%	36.76%	35.64%	36.67%	37.95%	33.27%	33.56%	32.05%	33.27%
EBITDA Margin	17.74%	26.70%	15.89%	14.01%	15.52%	16.72%	17.04%	11.24%	11.89%	12.43%	11.82%
Operating Margin	14.12%	23.09%	12.01%	9.02%	10.01%	12.42%	13.12%	8.79%	9.36%	10.19%	9.20%
EBIT Margin	13.83%	22.85%	11.85%	8.94%	10.18%	12.15%	12.83%	8.49%	9.50%	10.27%	9.78%
Profit (Net Income) Margin	10.14%	18.76%	8.35%	5.56%	3.34%	10.61%	6.15%	7.18%	6.93%	7.09%	5.99%
Tax Burden Percent	76.82%	84.78%	75.52%	69.21%	37.33%	101.40%	53.52%	91.34%	75.97%	71.92%	63.22%
Interest Burden Percent	95.44%	96.81%	93.26%	89.79%	87.86%	86.16%	89.49%	92.65%	95.98%	96.01%	96.79%
Effective Tax Rate	22.64%	15.12%	24.37%	26.86%	24.15%	27.90%	55.60%	23.20%	23.78%	27.42%	26.63%
Return on Invested Capital (ROIC)	13.10%	25.16%	11.73%	7.80%	8.48%	11.50%	7.18%	10.27%	15.46%	17.15%	16.31%
ROIC Less NNEP Spread (ROIC-NNEP)	53.95%	-0.92%	3.63%	-1.83%	-24.37%	37.51%	10.77%	18.06%	27.91%	36.94%	44.25%
Return on Net Nonoperating Assets (RNNOA)	-1.21%	-0.04%	0.48%	-0.27%	-4.12%	3.35%	1.33%	1.69%	-0.97%	-1.26%	-2.74%
Return on Equity (ROE)	11.89%	25.12%	12.21%	7.54%	4.36%	14.84%	8.52%	11.96%	14.49%	15.88%	13.57%
Cash Return on Invested Capital (CROIC)	7.94%	22.41%	11.77%	2.41%	9.08%	-6.36%	19.24%	-30.33%	19.77%	4.33%	6.04%
Operating Return on Assets (OROA)	9.82%	17.29%	9.19%	6.20%	6.64%	8.45%	8.56%	7.06%	10.58%	12.82%	12.87%
Return on Assets (ROA)	7.20%	14.19%	6.47%	3.85%	2.18%	7.39%	4.10%	5.97%	7.71%	8.85%	7.87%
Return on Common Equity (ROCE)	11.89%	25.12%	12.21%	7.54%	4.36%	14.84%	8.52%	11.96%	14.49%	15.88%	13.57%
Return on Equity Simple (ROE_SIMPLE)	11.76%	22.88%	12.29%	7.20%	4.37%	14.63%	8.12%	11.39%	14.07%	15.71%	12.58%
Net Operating Profit after Tax (NOPAT)	79	145	67	43	46	57	35	44	54	57	48
NOPAT Margin	10.92%	19.60%	9.08%	6.59%	7.59%	8.95%	5.83%	6.75%	7.13%	7.39%	6.75%
Net Nonoperating Expense Percent (NNEP)	-40.84%	26.07%	8.09%	9.63%	32.86%	-26.01%	-3.59%	-7.79%	-12.44%	-19.80%	-27.94%
Cost of Revenue to Revenue	60.87%	61.53%	63.29%	63.24%	64.36%	63.33%	62.05%	66.73%	66.44%	67.95%	66.73%
SG&A Expenses to Revenue	23.53%	23.26%	23.10%	24.85%	24.56%	23.49%	23.62%	22.39%	22.65%	21.48%	23.15%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.01%	15.38%	24.70%	27.75%	25.63%	24.25%	24.83%	24.48%	24.20%	21.87%	24.07%
Earnings before Interest and Taxes (EBIT)	100	169	87	59	62	78	76	55	71	79	70
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	128	198	117	92	94	107	101	73	89	96	85
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.07	2.75	2.01	2.24	1.49	1.89	2.73	2.64	2.65	0.00	0.00
Price to Tangible Book Value (P/TBV)	7.29	6.26	6.91	8.75	8.17	12.21	7.99	16.97	5.69	0.00	0.00
Price to Revenue (P/Rev)	2.65	2.26	1.37	1.73	1.14	1.37	2.07	1.66	1.30	0.00	0.00
Price to Earnings (P/E)	26.09	12.03	16.38	31.05	33.99	12.91	33.62	23.14	18.81	0.00	0.00
Dividend Yield	0.55%	0.78%	1.22%	1.02%	1.56%	1.13%	0.73%	0.73%	0.71%	0.63%	0.56%
Earnings Yield	3.83%	8.31%	6.10%	3.22%	2.94%	7.74%	2.97%	4.32%	5.32%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	3.09	2.82	1.89	2.10	1.42	1.81	2.90	2.31	2.80	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	2.64	2.23	1.46	1.82	1.27	1.53	2.21	1.82	1.26	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	14.88	8.34	9.21	13.01	8.17	9.17	12.96	16.21	10.62	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	19.08	9.74	12.34	20.37	12.45	12.62	17.21	21.46	13.29	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	24.16	11.36	16.11	27.63	16.70	17.13	37.90	27.00	17.70	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	20.52	18.17	13.84	14.30	16.23	13.38	20.25	18.61	11.82	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	39.85	12.75	16.06	89.42	15.60	0.00	14.15	0.00	13.84	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.24	0.29	0.35	0.39	0.43	0.43	0.43	0.47	0.25	0.29	0.13
Long-Term Debt to Equity	0.24	0.29	0.35	0.39	0.43	0.43	0.43	0.47	0.25	0.29	0.13
Financial Leverage	-0.02	0.04	0.13	0.15	0.17	0.09	0.12	0.09	-0.03	-0.03	-0.06
Leverage Ratio	1.65	1.77	1.89	1.96	2.00	2.01	2.08	2.00	1.88	1.79	1.72
Compound Leverage Factor	1.58	1.71	1.76	1.76	1.76	1.73	1.86	1.85	1.80	1.72	1.67
Debt to Total Capital	19.33%	22.21%	25.93%	28.26%	30.14%	29.85%	30.06%	31.96%	19.93%	22.60%	11.68%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	19.33%	22.21%	25.93%	28.26%	30.14%	29.85%	30.06%	31.96%	19.93%	22.60%	11.68%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	80.68%	77.79%	74.07%	71.74%	69.86%	70.15%	69.94%	68.04%	80.07%	77.40%	88.32%
Debt to EBITDA	1.16	0.88	1.50	2.17	2.12	1.85	1.91	2.64	1.03	1.06	0.53
Net Debt to EBITDA	-0.04	-0.11	0.60	0.69	0.86	0.98	0.83	1.42	-0.33	0.06	-0.35
Long-Term Debt to EBITDA	1.16	0.88	1.50	2.17	2.12	1.85	1.91	2.64	1.03	1.06	0.53
Debt to NOPAT	1.89	1.19	2.62	4.61	4.34	3.45	5.58	4.39	1.72	1.78	0.93
Net Debt to NOPAT	-0.07	-0.15	1.05	1.46	1.75	1.82	2.43	2.37	-0.56	0.10	-0.60
Long-Term Debt to NOPAT	1.89	1.19	2.62	4.61	4.34	3.45	5.58	4.39	1.72	1.78	0.93
Altman Z-Score	5.90	5.47	4.13	3.90	3.26	3.62	3.96	3.80	5.02	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.37	3.43	2.51	2.61	2.70	2.36	2.38	2.26	2.65	2.42	2.12
Quick Ratio	2.16	2.26	1.47	1.71	1.77	1.39	1.42	1.35	1.68	1.49	1.29
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	48	129	67	13	49	-32	93	-129	69	14	18
Operating Cash Flow to CapEx	456.48%	403.06%	352.12%	386.33%	221.37%	249.96%	313.42%	260.52%	459.84%	284.68%	375.65%
Free Cash Flow to Firm to Interest Expense	10.50	23.93	11.41	2.23	6.57	-2.95	11.57	-31.93	23.88	4.56	7.95
Operating Cash Flow to Interest Expense	20.39	16.80	13.23	13.95	6.32	6.82	8.09	15.69	27.98	20.26	31.26
Operating Cash Flow Less CapEx to Interest Expense	15.92	12.63	9.47	10.34	3.47	4.09	5.51	9.67	21.89	13.14	22.94
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.71	0.76	0.78	0.69	0.65	0.70	0.67	0.83	1.11	1.25	1.32
Accounts Receivable Turnover	5.89	6.16	6.48	6.31	6.00	5.74	4.83	5.61	7.01	7.08	6.96
Inventory Turnover	4.73	4.47	4.72	4.69	4.82	4.49	3.30	3.85	4.67	5.11	5.34
Fixed Asset Turnover	5.42	5.71	5.61	4.94	4.53	4.72	4.41	5.40	6.98	7.52	7.57
Accounts Payable Turnover	6.65	6.37	6.24	6.40	7.13	6.09	4.21	4.98	6.33	6.32	6.26
Days Sales Outstanding (DSO)	62.00	59.23	56.33	57.86	60.84	63.64	75.65	65.08	52.07	51.56	52.41
Days Inventory Outstanding (DIO)	77.24	81.60	77.33	77.80	75.67	81.33	110.48	94.90	78.11	71.44	68.31
Days Payable Outstanding (DPO)	54.91	57.29	58.54	57.03	51.18	59.96	86.65	73.28	57.70	57.73	58.33
Cash Conversion Cycle (CCC)	84.33	83.55	75.12	78.63	85.33	85.01	99.49	86.70	72.48	65.27	62.38
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	616	585	569	570	540	543	454	512	339	354	312
Invested Capital Turnover	1.20	1.28	1.29	1.18	1.12	1.28	1.23	1.52	2.17	2.32	2.42
Increase / (Decrease) in Invested Capital	31	16	-0.22	30	-3.22	89	-58	173	-15	43	30
Enterprise Value (EV)	1,901	1,650	1,076	1,196	767	981	1,315	1,180	949	0.00	0.00
Market Capitalization	1,907	1,672	1,006	1,132	686	877	1,231	1,077	979	0.00	0.00
Book Value per Share	$52.43	$51.03	$41.37	$41.30	$37.20	$36.70	$35.13	$32.06	$28.89	$27.54	$27.01
Tangible Book Value per Share	$22.07	$22.43	$12.07	$10.56	$6.77	$5.68	$12.01	$4.98	$13.45	$12.31	$14.53
Total Capital	770	781	674	706	661	662	645	601	462	450	386
Total Debt	149	173	175	199	199	198	194	192	92	102	45
Total Long-Term Debt	149	173	175	199	199	198	194	192	92	102	45
Net Debt	-5.33	-22	70	63	80	104	84	103	-30	5.63	-29
Capital Expenditures (CapEx)	20	23	22	22	21	29	21	24	17	22	19
Debt-free, Cash-free Net Working Capital (DFCFNWC)	148	147	123	94	90	99	113	112	100	100	85
Debt-free Net Working Capital (DFNWC)	303	342	228	231	209	192	223	201	222	197	159
Net Working Capital (NWC)	303	342	228	231	209	192	223	201	222	197	159
Net Nonoperating Expense (NNE)	5.63	6.22	5.39	6.80	26	-11	-1.91	-2.83	1.56	2.33	5.46
Net Nonoperating Obligations (NNO)	-5.33	-22	70	63	78	79	3.06	103	-31	5.63	-29
Total Depreciation and Amortization (D&A)	28	28	30	33	32	29	25	18	18	17	15
Debt-free, Cash-free Net Working Capital to Revenue	20.58%	19.78%	16.78%	14.37%	14.94%	15.49%	18.98%	17.34%	13.27%	13.01%	11.80%
Debt-free Net Working Capital to Revenue	41.98%	46.19%	31.04%	35.15%	34.59%	30.04%	37.38%	31.01%	29.50%	25.46%	22.17%
Net Working Capital to Revenue	41.98%	46.19%	31.04%	35.15%	34.59%	30.04%	37.38%	31.01%	29.50%	25.46%	22.17%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$6.22	$11.77	$5.13	$3.00	$1.64	$5.40	$2.88	$3.68	$4.11	$4.33	$3.39
Adjusted Weighted Average Basic Shares Outstanding	11.85M	11.85M	11.97M	12.21M	12.38M	12.45M	12.83M	12.78M	12.78M	12.77M	12.76M
Adjusted Diluted Earnings per Share	$6.14	$11.58	$5.06	$2.97	$1.63	$5.38	$2.86	$3.65	$4.08	$4.27	$3.35
Adjusted Weighted Average Diluted Shares Outstanding	11.85M	11.85M	11.97M	12.21M	12.38M	12.45M	12.83M	12.78M	12.78M	12.77M	12.76M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	11.85M	11.85M	11.97M	12.21M	12.38M	12.45M	12.83M	12.78M	12.78M	12.77M	12.76M
Normalized Net Operating Profit after Tax (NOPAT)	87	96	71	57	51	60	60	54	57	60	56
Normalized NOPAT Margin	12.06%	12.99%	9.70%	8.72%	8.40%	9.45%	10.03%	8.36%	7.56%	7.72%	7.78%
Pre Tax Income Margin	13.20%	22.12%	11.05%	8.03%	8.94%	10.47%	11.48%	7.87%	9.12%	9.86%	9.47%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	21.93	31.33	14.84	9.80	8.23	7.22	9.52	13.60	24.87	25.08	31.15
NOPAT to Interest Expense	17.32	26.87	11.37	7.22	6.14	5.33	4.32	10.81	18.68	18.06	21.49
EBIT Less CapEx to Interest Expense	17.47	27.16	11.08	6.18	5.38	4.50	6.94	7.58	18.78	17.96	22.83
NOPAT Less CapEx to Interest Expense	12.85	22.70	7.61	3.61	3.29	2.60	1.74	4.79	12.59	10.94	13.17
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	19.02%	9.34%	19.95%	31.39%	52.54%	14.47%	24.28%	16.87%	13.15%	10.63%	11.18%
Augmented Payout Ratio	62.57%	27.71%	71.14%	89.52%	104.24%	63.64%	31.53%	33.64%	23.98%	29.55%	29.35%

This table displays calculated financial ratios and metrics derived from Standex International's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	17.21%	6.40%	-7.74%	-4.32%	-3.83%	-5.00%	2.31%	1.94%	-2.61%	1.12%	2.84%
EBITDA Growth	25.70%	-50.36%	-5.93%	-4.94%	-70.14%	-7.02%	2.70%	36.91%	203.58%	20.19%	5.73%
EBIT Growth	22.29%	-70.30%	-7.46%	-5.47%	-75.83%	-8.52%	3.16%	51.72%	263.74%	29.75%	10.82%
NOPAT Growth	98.00%	-72.89%	-7.68%	-1.14%	-79.20%	-5.19%	2.58%	44.28%	343.81%	29.46%	16.72%
Net Income Growth	43.85%	-93.24%	-3.28%	-2.87%	-80.38%	-5.85%	2.98%	52.00%	364.78%	33.76%	15.50%
EPS Growth	36.09%	-95.60%	-3.16%	3.14%	-80.35%	-5.92%	3.27%	34.75%	405.22%	36.29%	17.69%
Operating Cash Flow Growth	-60.85%	-61.56%	8.61%	-29.49%	4.68%	-20.77%	698.59%	37.40%	95.32%	27.85%	-120.68%
Free Cash Flow Firm Growth	-6,275.87%	-3,192.43%	17.80%	-291.31%	-111.28%	-407.48%	-160.07%	-64.49%	815.53%	-84.51%	-21.82%
Invested Capital Growth	88.27%	74.83%	4.23%	5.30%	4.20%	5.77%	4.97%	2.78%	1.71%	2.89%	0.96%
Revenue Q/Q Growth	9.47%	11.35%	-5.40%	1.65%	-0.64%	-3.45%	-1.89%	2.17%	-1.84%	3.98%	-2.24%
EBITDA Q/Q Growth	121.97%	-48.45%	-7.93%	19.31%	-12.34%	-2.31%	-6.97%	-62.52%	172.95%	7.91%	24.02%
EBIT Q/Q Growth	242.59%	-68.61%	-10.25%	26.71%	-16.80%	-2.19%	-8.32%	-67.60%	214.86%	10.30%	34.83%
NOPAT Q/Q Growth	523.46%	-71.19%	-9.38%	21.62%	-14.64%	-1.87%	-2.96%	-74.41%	289.07%	6.17%	36.49%
Net Income Q/Q Growth	1,682.43%	-92.99%	-7.12%	24.01%	-16.28%	0.30%	-6.72%	-74.95%	301.69%	9.70%	37.69%
EPS Q/Q Growth	2,485.71%	-95.42%	-6.71%	23.31%	-16.35%	0.63%	-0.63%	-76.51%	300.59%	10.46%	29.66%
Operating Cash Flow Q/Q Growth	5.32%	-48.46%	-38.44%	17.14%	3.40%	45.64%	-60.03%	73.91%	-21.74%	1,200.37%	-109.17%
Free Cash Flow Firm Q/Q Growth	-12.42%	-6,402.04%	29.40%	-23.55%	41.95%	-62.33%	-264.30%	-92.71%	1,482.19%	-68.28%	-2.89%
Invested Capital Q/Q Growth	8.06%	70.58%	4.26%	-2.03%	0.34%	1.70%	5.33%	-3.05%	1.86%	0.92%	3.13%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	39.67%	37.64%	41.11%	38.52%	38.52%	40.17%	39.31%	39.09%	38.46%	38.51%	37.79%
EBITDA Margin	17.18%	8.47%	18.30%	18.80%	16.02%	18.15%	17.94%	18.92%	51.58%	18.55%	17.87%
Operating Margin	12.64%	4.46%	14.14%	15.07%	12.32%	14.48%	14.57%	15.12%	48.02%	14.81%	14.56%
EBIT Margin	12.49%	3.99%	14.15%	14.92%	11.97%	14.29%	14.11%	15.10%	47.62%	14.84%	13.99%
Profit (Net Income) Margin	10.94%	0.67%	10.68%	10.87%	8.91%	10.58%	10.18%	10.71%	43.68%	10.67%	10.12%
Tax Burden Percent	129.26%	63.81%	78.60%	76.58%	77.95%	77.08%	75.88%	74.15%	93.23%	76.18%	75.86%
Interest Burden Percent	67.77%	26.38%	95.95%	95.16%	95.53%	96.00%	95.11%	95.65%	98.39%	94.38%	95.30%
Effective Tax Rate	-29.56%	35.54%	21.43%	23.04%	21.35%	22.09%	23.81%	25.78%	6.70%	23.66%	23.95%
Return on Invested Capital (ROIC)	13.51%	2.40%	12.46%	13.91%	11.46%	13.61%	13.75%	14.41%	55.20%	14.36%	14.02%
ROIC Less NNEP Spread (ROIC-NNEP)	8.80%	0.40%	-11.60%	23.35%	-22.98%	10.00%	10.85%	10.36%	48.71%	12.32%	11.93%
Return on Net Nonoperating Assets (RNNOA)	3.17%	0.13%	-0.06%	-0.52%	-0.15%	0.60%	1.17%	0.45%	2.75%	1.35%	1.95%
Return on Equity (ROE)	16.68%	2.52%	12.41%	13.39%	11.31%	14.22%	14.92%	14.85%	57.95%	15.72%	15.98%
Cash Return on Invested Capital (CROIC)	-52.64%	-47.10%	8.11%	7.94%	8.69%	18.11%	19.37%	22.41%	21.50%	9.90%	10.97%
Operating Return on Assets (OROA)	7.33%	2.30%	9.90%	10.59%	8.68%	10.72%	11.05%	11.42%	35.31%	11.44%	11.01%
Return on Assets (ROA)	6.42%	0.39%	7.47%	7.72%	6.47%	7.94%	7.98%	8.10%	32.39%	8.22%	7.96%
Return on Common Equity (ROCE)	16.33%	2.47%	12.41%	13.39%	11.31%	14.22%	14.92%	14.85%	57.95%	15.72%	15.98%
Return on Equity Simple (ROE_SIMPLE)	9.00%	8.36%	11.01%	0.00%	11.90%	22.30%	23.47%	0.00%	21.81%	13.02%	12.98%
Net Operating Profit after Tax (NOPAT)	34	5.46	19	21	17	20	21	21	83	21	20
NOPAT Margin	16.37%	2.87%	11.11%	11.59%	9.69%	11.28%	11.10%	11.22%	44.80%	11.30%	11.07%
Net Nonoperating Expense Percent (NNEP)	4.71%	1.99%	24.07%	-9.44%	34.44%	3.61%	2.89%	4.04%	6.49%	2.05%	2.10%
Return On Investment Capital (ROIC_SIMPLE)	2.69%	0.46%	-	-	-	2.62%	-	-	-	-	-
Cost of Revenue to Revenue	60.33%	62.36%	58.89%	61.48%	61.48%	59.83%	60.69%	60.91%	61.54%	61.49%	62.21%
SG&A Expenses to Revenue	25.05%	24.06%	25.25%	22.74%	23.56%	24.26%	23.59%	23.67%	23.30%	23.28%	22.75%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	27.04%	33.18%	26.97%	23.46%	26.20%	25.69%	24.74%	23.97%	-9.56%	23.70%	23.24%
Earnings before Interest and Taxes (EBIT)	26	7.57	24	27	21	26	26	28	88	28	25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	36	16	31	34	28	32	33	36	95	35	32
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.80	3.44	3.29	3.07	3.48	3.02	2.89	2.75	2.39	2.29	1.96
Price to Tangible Book Value (P/TBV)	0.00	0.00	7.55	7.29	8.45	7.27	7.28	6.26	5.65	6.83	6.47
Price to Revenue (P/Rev)	2.57	3.15	3.07	2.65	2.96	2.54	2.30	2.26	1.96	1.63	1.30
Price to Earnings (P/E)	31.73	41.50	29.90	26.09	29.27	13.53	12.30	12.03	10.97	17.61	15.08
Dividend Yield	0.77%	0.65%	0.49%	0.55%	0.47%	0.71%	0.77%	0.78%	0.89%	1.05%	1.29%
Earnings Yield	3.15%	2.41%	3.34%	3.83%	3.42%	7.39%	8.13%	8.31%	9.12%	5.68%	6.63%
Enterprise Value to Invested Capital (EV/IC)	2.04	2.46	3.35	3.09	3.44	3.00	2.82	2.82	2.40	2.17	1.80
Enterprise Value to Revenue (EV/Rev)	3.23	3.76	3.05	2.64	2.97	2.55	2.33	2.23	1.96	1.73	1.43
Enterprise Value to EBITDA (EV/EBITDA)	20.69	24.64	17.09	14.88	16.71	9.57	8.75	8.34	7.69	10.34	8.92
Enterprise Value to EBIT (EV/EBIT)	28.60	33.82	22.01	19.08	21.39	11.19	10.22	9.74	9.06	13.41	11.81
Enterprise Value to NOPAT (EV/NOPAT)	31.01	42.64	27.89	24.16	27.43	12.99	11.93	11.36	10.42	17.28	15.20
Enterprise Value to Operating Cash Flow (EV/OCF)	37.35	33.93	22.87	20.52	20.70	18.14	15.85	18.17	18.14	18.81	17.09
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	42.12	39.85	40.41	17.01	14.92	12.75	11.24	22.26	16.52
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.81	0.78	0.23	0.24	0.24	0.24	0.25	0.29	0.29	0.35	0.40
Long-Term Debt to Equity	0.81	0.78	0.23	0.24	0.24	0.24	0.25	0.29	0.29	0.35	0.40
Financial Leverage	0.36	0.32	0.00	-0.02	0.01	0.06	0.11	0.04	0.06	0.11	0.16
Leverage Ratio	1.91	1.91	1.61	1.65	1.64	1.71	1.75	1.77	1.75	1.83	1.87
Compound Leverage Factor	1.29	0.50	1.55	1.57	1.57	1.64	1.67	1.69	1.73	1.73	1.79
Debt to Total Capital	44.78%	43.90%	18.46%	19.33%	19.38%	19.33%	19.99%	22.21%	22.25%	26.15%	28.80%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	44.78%	43.90%	18.46%	19.33%	19.38%	19.33%	19.99%	22.21%	22.25%	26.15%	28.80%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.13%	2.19%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	53.09%	53.91%	81.54%	80.68%	80.62%	80.67%	80.01%	77.79%	77.75%	73.85%	71.20%
Debt to EBITDA	4.96	4.88	1.18	1.16	1.15	0.76	0.75	0.88	0.92	1.51	1.68
Net Debt to EBITDA	4.02	3.77	-0.12	-0.04	0.08	0.03	0.11	-0.11	-0.01	0.59	0.81
Long-Term Debt to EBITDA	4.96	4.88	1.18	1.16	1.15	0.76	0.75	0.88	0.92	1.51	1.68
Debt to NOPAT	7.43	8.44	1.93	1.89	1.88	1.03	1.02	1.19	1.25	2.52	2.86
Net Debt to NOPAT	6.02	6.53	-0.20	-0.07	0.13	0.04	0.15	-0.15	-0.01	0.99	1.37
Long-Term Debt to NOPAT	7.43	8.44	1.93	1.89	1.88	1.03	1.02	1.19	1.25	2.52	2.86
Altman Z-Score	3.18	3.50	6.04	5.66	6.12	5.57	5.35	5.02	4.92	4.28	3.97
Noncontrolling Interest Sharing Ratio	2.07%	2.04%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.40	3.37	3.55	3.37	3.43	3.34	3.19	3.43	3.53	3.03	3.09
Quick Ratio	1.95	1.99	2.25	2.16	2.12	2.05	1.93	2.26	2.27	1.76	1.74
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-521	-464	-7.13	-10	-8.17	-14	-8.67	5.28	72	4.58	14
Operating Cash Flow to CapEx	157.11%	130.05%	261.31%	436.92%	470.59%	554.60%	372.98%	531.13%	414.20%	516.28%	-51.32%
Free Cash Flow to Firm to Interest Expense	-62.31	-83.15	-7.30	-7.77	-8.61	-13.82	-6.80	4.27	51.20	2.92	12.16
Operating Cash Flow to Interest Expense	1.14	1.62	17.99	21.96	25.68	23.13	12.68	32.73	16.45	18.99	-2.28
Operating Cash Flow Less CapEx to Interest Expense	0.41	0.38	11.10	16.93	20.22	18.96	9.28	26.57	12.48	15.31	-6.71
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.59	0.58	0.70	0.71	0.73	0.75	0.78	0.76	0.74	0.77	0.79
Accounts Receivable Turnover	5.15	5.15	5.75	5.89	6.03	6.00	6.19	6.16	6.23	6.54	6.76
Inventory Turnover	4.23	4.33	4.53	4.73	4.43	4.38	4.38	4.47	4.41	4.49	4.47
Fixed Asset Turnover	5.31	5.31	5.28	5.42	5.49	5.61	5.87	5.71	5.70	5.73	5.77
Accounts Payable Turnover	6.74	6.39	6.64	6.65	7.03	6.87	7.10	6.37	6.44	6.60	6.43
Days Sales Outstanding (DSO)	70.82	70.88	63.53	62.00	60.52	60.88	58.95	59.23	58.55	55.80	53.98
Days Inventory Outstanding (DIO)	86.31	84.31	80.55	77.24	82.35	83.40	83.26	81.60	82.80	81.27	81.72
Days Payable Outstanding (DPO)	54.14	57.13	54.97	54.91	51.94	53.16	51.40	57.29	56.72	55.34	56.80
Cash Conversion Cycle (CCC)	103.00	98.05	89.11	84.33	90.92	91.13	90.81	83.55	84.63	81.74	78.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,184	1,096	642	616	629	627	616	585	604	593	587
Invested Capital Turnover	0.83	0.83	1.12	1.20	1.18	1.21	1.24	1.28	1.23	1.27	1.27
Increase / (Decrease) in Invested Capital	555	469	26	31	25	34	29	16	10	17	5.56
Enterprise Value (EV)	2,417	2,699	2,151	1,901	2,165	1,878	1,739	1,650	1,447	1,287	1,058
Market Capitalization	1,920	2,259	2,167	1,907	2,155	1,872	1,717	1,672	1,449	1,213	963
Book Value per Share	$57.73	$54.30	$55.51	$52.43	$52.14	$52.15	$50.19	$51.03	$50.70	$44.17	$41.09
Tangible Book Value per Share	($12.66)	($11.44)	$24.20	$22.07	$21.49	$21.64	$19.89	$22.43	$21.48	$14.83	$12.44
Total Capital	1,294	1,217	807	770	768	769	743	781	779	717	691
Total Debt	579	534	149	149	149	149	149	173	173	188	199
Total Long-Term Debt	579	534	149	149	149	149	149	173	173	188	199
Net Debt	470	413	-16	-5.33	9.97	6.24	22	-22	-1.95	74	95
Capital Expenditures (CapEx)	6.07	6.97	6.73	6.53	5.18	4.25	4.34	7.62	5.62	5.76	5.27
Debt-free, Cash-free Net Working Capital (DFCFNWC)	234	206	157	148	158	163	162	147	155	155	157
Debt-free Net Working Capital (DFNWC)	344	327	321	303	297	305	288	342	330	269	260
Net Working Capital (NWC)	344	327	321	303	297	305	288	342	330	269	260
Net Nonoperating Expense (NNE)	11	4.18	0.74	1.30	1.38	1.25	1.69	0.96	2.07	1.18	1.72
Net Nonoperating Obligations (NNO)	470	413	-16	-5.33	9.97	6.24	22	-22	-1.95	63	95
Total Depreciation and Amortization (D&A)	9.74	8.51	7.06	6.99	7.18	6.89	7.08	7.20	7.31	6.96	7.01
Debt-free, Cash-free Net Working Capital to Revenue	31.27%	28.65%	22.17%	20.58%	21.68%	22.16%	21.68%	19.78%	21.01%	20.88%	21.21%
Debt-free Net Working Capital to Revenue	45.95%	45.53%	45.47%	41.98%	40.73%	41.51%	38.70%	46.19%	44.77%	36.17%	35.18%
Net Working Capital to Revenue	45.95%	45.53%	45.47%	41.98%	40.73%	41.51%	38.70%	46.19%	44.77%	36.17%	35.18%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.83	$0.07	$1.54	$1.68	$1.34	$1.60	$1.60	$1.71	$6.82	$1.69	$1.55
Adjusted Weighted Average Basic Shares Outstanding	11.99M	11.94M	11.79M	11.85M	11.77M	11.79M	11.74M	11.85M	11.81M	11.85M	11.82M
Adjusted Diluted Earnings per Share	$1.81	$0.07	$1.53	$1.64	$1.33	$1.59	$1.58	$1.59	$6.77	$1.69	$1.53
Adjusted Weighted Average Diluted Shares Outstanding	12.06M	12.03M	11.90M	11.85M	11.85M	11.86M	11.93M	11.85M	11.90M	11.92M	11.95M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	12.07M	11.90M	12.08M	11.85M	11.85M	11.87M	11.90M	11.85M	11.90M	11.94M	11.99M
Normalized Net Operating Profit after Tax (NOPAT)	21	17	21	22	21	22	22	22	27	22	21
Normalized NOPAT Margin	10.24%	8.76%	12.46%	12.15%	11.72%	12.40%	12.09%	11.45%	14.51%	11.58%	11.44%
Pre Tax Income Margin	8.46%	1.05%	13.58%	14.20%	11.43%	13.72%	13.42%	14.44%	46.85%	14.01%	13.34%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.10	1.36	24.70	20.68	22.36	25.02	20.43	22.99	62.03	17.80	21.29
NOPAT to Interest Expense	4.07	0.98	19.38	16.07	18.10	19.75	16.07	17.08	58.36	13.55	16.84
EBIT Less CapEx to Interest Expense	2.38	0.11	17.81	15.65	16.90	20.85	17.03	16.83	58.06	14.12	16.85
NOPAT Less CapEx to Interest Expense	3.34	-0.27	12.50	11.05	12.65	15.58	12.67	10.92	54.39	9.88	12.41
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	23.83%	26.29%	19.52%	19.02%	18.55%	9.70%	9.46%	9.34%	9.69%	18.33%	19.47%
Augmented Payout Ratio	39.41%	53.19%	38.91%	62.57%	71.13%	37.64%	37.62%	27.71%	31.33%	69.70%	66.96%

Frequently Asked Questions About Standex International's Financials

When does Standex International's fiscal year end?

According to the most recent income statement we have on file, Standex International's financial year ends in June. Their financial year 2024 ended on June 30, 2024.

How has Standex International's net income changed over the last 10 years?

Standex International's net income appears to be on an upward trend, with a most recent value of $73.07 million in 2024, rising from $42.87 million in 2014. The previous period was $138.99 million in 2023. View Standex International's forecast to see where analysts expect Standex International to go next.

What is Standex International's operating income?

Standex International's total operating income in 2024 was $101.74 million, based on the following breakdown:

Total Gross Profit: $282.00 million
Total Operating Expenses: $180.26 million

How has Standex International revenue changed over the last 10 years?

Over the last 10 years, Standex International's total revenue changed from $716.18 million in 2014 to $720.64 million in 2024, a change of 0.6%.

How much debt does Standex International have?

Standex International's total liabilities were at $383.55 million at the end of 2024, a 8.1% decrease from 2023, and a 61.5% increase since 2014.

How much cash does Standex International have?

In the past 10 years, Standex International's cash and equivalents has ranged from $74.26 million in 2014 to $195.71 million in 2023, and is currently $154.20 million as of their latest financial filing in 2024.

How has Standex International's book value per share changed over the last 10 years?

Over the last 10 years, Standex International's book value per share changed from 27.01 in 2014 to 52.43 in 2024, a change of 94.1%.

Related Companies

This page (NYSE:SXI) was last updated on 5/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Standex International (SXI) Financials

Frequently Asked Questions About Standex International's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Standex International (SXI) Financials

Annual Income Statements for Standex International

Quarterly Income Statements for Standex International

Annual Cash Flow Statements for Standex International

Quarterly Cash Flow Statements for Standex International

Annual Balance Sheets for Standex International

Quarterly Balance Sheets for Standex International

Annual Metrics And Ratios for Standex International

Quarterly Metrics And Ratios for Standex International

Frequently Asked Questions About Standex International's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools